Pixium Vision

Pixium Vision ROCE

Delisted

The Return on Capital Employed (ROCE) of Pixium Vision (ALPIX.PA) as of Nov 4, 2026 is 419.12 %. In the previous year, Return on Capital Employed (ROCE) was -176.47 % — a change of -337.50% (higher).

ROCE

419.12 %

YoY

-337.50%

Last updated:

In 2022, Pixium Vision's return on capital employed (ROCE) was 419.12 %, a -337.50% increase from the -176.47 % ROCE in the previous year.

The Pixium Vision ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2015
-44.90 EUR
Jan 1, 2016
-53.76 EUR
Jan 1, 2017
-107.01 EUR
Jan 1, 2018
-59.99 EUR
Jan 1, 2019
-237.83 EUR
Jan 1, 2020
-178.44 EUR
Jan 1, 2021
-176.47 EUR
Jan 1, 2022
419.12 EUR
The Pixium Vision ROCE history
YEARROCEYoY
419.12 %-337.50%
-176.47 %-1.10%
-178.44 %-24.97%
-237.83 %+296.43%
-59.99 %-43.94%
-107.01 %+99.04%
-53.76 %+19.73%
-44.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pixium Vision Stock analysis

What does Pixium Vision do? Pixium Vision SA develops implantable medical devices for treating blindness caused by retinal photoreceptor cell degeneration. The company focuses on two Vision Restoration Systems (VRS) platforms, IRIS and PRIMA, which electrically stimulate retinal cells to restore partial vision in patients with retinitis pigmentosa. Pixium Vision collaborates with academic institutions like Institut de la Vision, Universite Pierre et Marie Curie, Stanford University, and University of Ulm to advance its retinal implant technology. The firm generates revenue through the development and commercialization of these medical devices, targeting patients with specific retinal conditions and healthcare providers in the ophthalmology sector. Pixium Vision SA's primary products, the IRIS and PRIMA systems, are designed to restore partial vision for patients suffering from retinitis pigmentosa. The company partners with academic institutions such as the Institut de la Vision and Universite Pierre et Marie Curie to conduct research and development on retinal implants. Revenue is derived from the sale of these Vision Restoration Systems to hospitals and clinics specializing in ophthalmology, where they are used to treat patients with degenerative retinal diseases. The company's focus on developing implantable medical devices for vision restoration positions it within the medical technology sector, serving patients with specific visual impairments. The firm's Vision Restoration Systems (VRS) platforms, IRIS and PRIMA, enable patients with retinitis pigmentosa to partially recover vision through electrical stimulation of retinal cells. Pixium Vision collaborates with technology and academic institutions including Institut de la Vision, Universite Pierre et Marie Curie, Stanford University, and University of Ulm to support its R&D efforts. Revenue streams come from the commercialization of these medical devices, sold to healthcare providers in the ophthalmology field who treat patients with retinal degeneration. The company's business model centers on developing and selling implantable devices for vision restoration, targeting a niche medical market with specific patient needs. Pixium Vision is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Pixium Vision's Return on Capital Employed (ROCE)

Pixium Vision's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Pixium Vision's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Pixium Vision's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Pixium Vision’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Pixium Vision stock

Return on Capital Employed (ROCE) of Pixium Vision is 419.12 % in 2022.

Return on Capital Employed (ROCE) of Pixium Vision changed from -176.47 % to 419.12 %, representing a -337.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Pixium Vision since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Pixium Vision with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Pixium Vision

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Pixium Vision